Stock Events

Stock Events

Seres Therapeutics (MCRB) Q2 2026 Earnings

5MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-2.49

-0.41

1.67

3.75

Details

Expected EPS

-1.88

Actual EPS

-2.08

Surprise EPS

-0.2

Surprise Percent

+10.64%

Description

Seres Therapeutics (MCRB) has reported earnings of -2.08 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.